22 May 2013
Keywords: ariad, pharmaceuticals, stock, sale, biotechnology, concern, usa
Article | 06 April 1992
The biotechnology concern Ariad Pharmaceuticals of the USA is reported
to have raised $46 million in a private stock sale, according ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 April 1992
21 May 2013
© 2013 thepharmaletter.com